Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Kidney Fat in Type 2 Diabetes and Diabetic Kidney Disease – Ezetimibe Trial
2020-001155-40Phase 4Completed
- Sponsor
- Steno Diabetes Center Copenhagen
- Start
- Apr 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of ezetimibe in type 2 diabetes mellitus (T2DM) and diabetic glomerulosclerosis (3 arms), sponsored by Steno Diabetes Center Copenhagen. Primary endpoints: Change in albuminuria and Change in kidney parenchymal triglyceride fraction. Started Apr 2020; status: completed.
02
Drugs
ezetimibe
03
Conditions
type 2 diabetes mellitus (T2DM)diabetic glomerulosclerosis
Beyond the preview
Go deeper on 2020-001155-40.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2020-001155-40.